Wuxi Biologics (Cayman) (1FW2) Revenue

5 Followers

Wuxi Biologics (Cayman) Revenue

Wuxi Biologics (Cayman) had a revenue of 11.79B in the quarter ending Jun 30, 2026, with -0.42%. This bring the company's revenue in the last twelve months to 23.62B, Decreased 8.42%. In the fiscal year ending Dec 31, 2025, Wuxi Biologics (Cayman) had annual revenue of 21.79B with 16.68% growth.

Revenue (ttm)

23.62B

Revenue Growth

13.33%

P/S Ratio

1.04

Revenue/Employee

€1,481,810

Employees

14,705

Market Cap

€22.56B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	21.79B	3.11B	+16.68%
Dec 31, 2024	18.68B	1.64B	+9.63%
Dec 31, 2023	17.03B	1.77B	+11.56%
Dec 31, 2022	15.27B	4.98B	+48.38%
Dec 31, 2021	10.29B	4.68B	+83.35%
Dec 31, 2020	5.61B	1.63B	+40.88%
Dec 31, 2019	3.98B	1.45B	+57.18%
Dec 31, 2018	2.53B	915.62M	+56.56%
Dec 31, 2017	1.62B	―	―